Pretarget technology (NeoRx)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePretarget technology (NeoRx)

Drug Alias NameCC49-streptavidin fusion protein (NeoRx)Pretarget technology (NeoRx)anti-TAG-72 radioimmunotherapy (NeoRx)intraperitoneal radioimmunotherapy (NeoRx)B9E9

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusSuspended

Highest Status in ChinaN/A

Originator CompaniesPoniard Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesPoniard Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsGastrointestinal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A